Skip to main content
Back

Disorders of Blood Flow: Hyperlipidemia, Atherosclerosis, Arterial and Venous Disorders

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Disorders of Blood Flow

Introduction

Disorders of blood flow encompass a range of conditions affecting the arteries and veins, including hyperlipidemia, atherosclerosis, arterial diseases, and venous disorders. These conditions are central to cardiovascular pathophysiology and are critical topics in Anatomy & Physiology.

Hyperlipidemia & Lipid Laboratory Measurement

Key Lipid Types and Laboratory Values

Lipids such as cholesterol and triglycerides are measured to assess cardiovascular risk. Laboratory values are interpreted to determine optimal, borderline, and high-risk levels.

Type

Concentration (mg/dL)

Interpretation

Total Cholesterol

<200

Optimal

Total Cholesterol

200-239

Borderline high

Total Cholesterol

>240

High

LDL Cholesterol

<100

Optimal

LDL Cholesterol

100-129

Above optimal

LDL Cholesterol

130-159

Borderline high

LDL Cholesterol

160-189

High

LDL Cholesterol

>190

Very high

HDL Cholesterol

<40

Low

HDL Cholesterol

>60

High ("good cholesterol")

Triglycerides

<150

Normal

Triglycerides

150-199

Borderline high

Triglycerides

200-499

High

Triglycerides

>500

Very high

Key Point: HDL is considered "good cholesterol" due to its role in removing cholesterol from circulation.

Lipid Laboratory Measurement

  • Fasting State: Lipid panels are ideally measured after 12 hours fasting to clear chylomicrons and IDL from blood.

  • Non-fasting State: Only total cholesterol and HDL are accurate; LDL is commonly calculated.

  • LDL Calculation:

  • VLDL Approximation: VLDL is approximated by

Hyperlipidemia Disorders

Primary vs. Secondary Hyperlipidemia

  • Primary (Genetic): Familial hypercholesterolemia (Type 2a) is most common, caused by LDL receptor dysfunction leading to impaired hepatic LDL uptake and elimination.

  • Secondary (Acquired): Causes include high carbohydrate diet, certain medications (beta-blockers, glucocorticoids, antipsychotics, estrogen/progestin), obesity, diabetes mellitus, hypothyroidism, nephrotic syndrome, and liver disease.

Clinical Manifestations: Hyperlipidemia can present with xanthomas, pancreatitis (especially with hypertriglyceridemia), and increased risk for atherosclerosis-related diseases.

Atherosclerosis

Risk Factors

Atherosclerosis is the buildup of plaques in arterial walls, leading to reduced blood flow and increased risk of cardiovascular events.

Modifiable (Secondary)

Mechanism

Hypercholesterolemia

↑LDL: Substrate for plaque; ↓HDL: Cholesterol removal from circulation

Obesity

Proinflammatory cytokine release from adipose tissue

Hypertension (HTN)

Shear stress/damage to endothelium

Diabetes

↓LDL removal from circulation, glycation of proteins

Cigarette smoking

Endothelial damage

Hypothyroidism

↓LDL receptor production

Lipoprotein A/homocysteine

↑Oxidation of LDL

Non-modifiable (Primary)

Mechanism

Male gender

Estrogen ↑ LDL receptors (protective in females)

Genetic factors

Inherited lipid disorders

Clinical Manifestations of Atherosclerosis

  • Coronary arteries: Acute coronary syndromes (e.g., myocardial infarction)

  • Carotid/cerebral arteries: Ischemic stroke

  • Aorta: Aneurysms

  • Peripheral arteries: Peripheral arterial disease

  • Renal/mesenteric arteries: Kidney disease, intestinal ischemia

Arterial Disorders

Peripheral Artery Disease (PAD)

PAD is a manifestation of atherosclerosis affecting arteries of the lower extremities, most commonly the femoral and popliteal arteries.

  • Symptoms: Often asymptomatic until significant occlusion; intermittent claudication (pain/fatigue with exertion), rest pain, ulcerations, necrosis, gangrene, thinning skin, muscle wasting, weak/absent pulses.

  • Diagnosis: Clinical assessment and Ankle-Brachial Index (ABI). ABI < 0.9 is consistent with PAD. Sensitivity and specificity > 90%.

  • Treatment: Lifestyle modifications (exercise, diet), risk factor management, antiplatelet agents (aspirin, clopidogrel), and vasodilators (cilostazol).

Aneurysms and Dissections

Aneurysms are localized dilations of blood vessels, most commonly arteries. Dissections involve tearing of the vessel wall, often in the aorta.

  • Types of Aneurysms: Berry (saccular), Fusiform (circumferential), Saccular (localized bulge).

  • Risk Factors: Atherosclerosis, hypertension, congenital abnormalities, trauma, infection.

  • Clinical Manifestations: Thoracic aneurysms: substernal, neck, back pain, dyspnea, stridor, hoarseness, edema. Abdominal aneurysms: pulsating abdominal mass, pain, thrombus formation, distal emboli.

  • Rupture Risk: <4cm diameter: 2% risk; >5cm diameter: 10% risk. Treatment is surgical repair.

  • Aortic Dissection: Sudden intense pain (anterior chest for ascending, back for descending), paralysis, syncope, heart failure, limb ischemia. Treatment: blood pressure control (beta-blockers, vasodilators), surgical resection with graft.

Venous Disorders

Venous Thromboembolism (VTE)

VTE includes deep vein thrombosis (DVT) and pulmonary embolism (PE), resulting from blood clots in the venous system.

  • Pathophysiology: Virchow’s Triad: stasis (low blood flow), hypercoagulability, vascular trauma (endothelial damage).

  • Risk Factors: Immobility, trauma, surgery, cancer, inherited clotting disorders (Factor V Leiden, protein C/S deficiency), hormone therapy, obesity, dehydration.

  • Clinical Manifestations: Often asymptomatic; unilateral pain, tenderness, swelling, elevated WBC, positive D-dimer. Complications include pulmonary embolism.

  • Laboratory Assessment: D-dimer < 500 ng/ml is considered negative for VTE; higher values require further testing.

  • Prevention: Early ambulation, pneumatic compression devices, compression stockings, prophylactic anticoagulation (heparin, low molecular weight heparin).

  • Treatment: Thrombolytic therapy (TPA), anticoagulants (warfarin, heparin, factor Xa inhibitors).

Chronic Venous Disease

Chronic venous disease results from increased venous pressure and compromised venous return, most evident in the lower extremities.

  • Risk Factors: Age (>50 years), female gender, obesity, sedentary lifestyle, prolonged sitting/standing, smoking, family history, height.

  • Pathophysiology: Venous wall stress leads to inflammation, hypoxia, wall remodeling (thickening, dilation), increased endothelial permeability, leukocyte and RBC extravasation, tissue deposition of fibrin and hemosiderin, collagen synthesis, decreased elastin.

  • Clinical Manifestations: Progressive disease with varicose veins, lower limb edema, discomfort, skin changes (brown pigmentation, stasis dermatitis), lipodermatosclerosis, venous ulcers.

Varicose Veins

Varicose veins are dilated, tortuous veins, most commonly affecting the saphenous and deep veins of the lower extremities.

  • Pathophysiology: Incompetent venous valves and impaired muscle pump function lead to blood pooling and vein dilation.

  • Clinical Manifestations: Visible, twisted veins, leg pain, heaviness, edema, and increased risk for chronic venous insufficiency.

Chronic Venous Insufficiency

Chronic venous insufficiency is characterized by dilated veins, tissue edema, leg pain, heaviness, tenderness, intermittent claudication, and cutaneous changes (lipodermatosclerosis, brown pigmentation, stasis dermatitis). It accounts for 80% of venous ulcers.

Example: A patient with a history of prolonged standing presents with swollen, discolored lower legs and visible varicose veins, consistent with chronic venous disease.

Additional info: Some details were inferred and expanded for completeness, including definitions, mechanisms, and clinical context.

Pearson Logo

Study Prep